Form 4 for ENTX Entera Bio Ltd.
Accepted 2024-04-23 00:00:00 ET · period of report 2024-04-19 · accession 0001178913-24-001423 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-23 | 2024-04-19 | ENTX | Yaacov-Garbeli Dana | CFO | A - Grant | $0.00 | +30.2K | 86.7K | +53% | $0 |
| D | 2024-04-23 | 2024-04-19 | ENTX | Yaacov-Garbeli Dana | CFO | A - Grant | $0.00 | +130.0K | 130.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares, par value NIS 0.0000769 per share | 2024-04-19 | A | A | 30,151 | $0.00 | 86,731 | D | — | — | (F1) Represent a grant of stock-settled restricted stock units. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 19, 2024. |
| 2 | Derivative | Stock Option (right to buy) | 2024-04-19 | A | A | 130,000 | $0.00 | 130,000 | D | $1.99 · — to 2034-04-19 | 130,000 Ordinary Shares, par value NIS 0.0000769 per share | (F2) The options vest over a three-year period with 33% of the options vesting on April 19, 2025, the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining two-year period. |